Encompass Health Corporation (EHC)
NYSE: EHCHealthcareMedical Care FacilitiesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 122.48 0.00%
EHC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $12.08B
- P/E (TTM)
- 20.48
- Forward P/E
- 18.34
- EPS (TTM)
- $5.98
- Dividend yield
- 0.62% ($0.76)
- Ex-dividend date
- Oct 1, 2026
- 52-week range
- 92.77 – 127.99
- Day range
- 121.99 – 125.45
- Volume / Avg
- 875.24K / 919.46K
- Beta
- —
- Shares outstanding
- 98.65M
- Next earnings
- Oct 28, 2026
52-week range
EHC stock today
Shares of Encompass Health (EHC) finished lower on Oct 7 at $122.48, a drop of 1.77% or $2.21 per share, versus the S&P 500's 0.22% decline. At this level, EHC sits near the top of its 52-week range of $92.77 to $127.99: 4.3% below the high, set on Oct 24, 2025 and 32.0% above the low. EHC is up 15.3% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 2.2%.
At 20.5x trailing earnings, Encompass Health trades below the peer-group median of 23.5x. Its forward P/E of 18.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. The company is scheduled to report Sep/2026 results on Oct 28 after the market closes; analysts expect EPS of $1.37. Encompass Health pays an annual dividend of $0.76 per share, a 0.62% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Encompass Health
Company profileEncompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- CEO
- Mr. Mark J. Tarr
- Headquarters
- Birmingham, AL
- Employees
- 29,699
- Website
- encompasshealth.com
Financial highlights
Full financialsIn fiscal 2025, Encompass Health generated $5.94 billion in revenue, up 10.5% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $566.2 million (+24.2% year over year), for a net margin of 9.5% versus a median of 8.0% in the prior 5 years. Diluted earnings per share came in at $5.54, up from $4.46.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $5.94B | $5.37B | $4.80B | $4.35B | $4.01B |
| Growth | +10.46% | +11.91% | +10.41% | +8.31% | +12.58% |
| Net income | $566.20M | $455.70M | $352.00M | $271.00M | $412.20M |
| EPS (diluted) | $5.54 | $4.46 | $3.47 | $2.70 | $4.11 |
Analyst forecast
ForecastConsensus (13 analysts)
strong_buy
Avg. price target
$148.17+20.97%
- Strong buy 1
- Buy 12
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Oct 28, 2026
- EPS estimate
- $1.37
- Last reported (Q2 2026)
- Aug 7, 2026
- EPS actual vs est.
- $1.54 vs —
Dividends
Dividend history- Annual dividend
- $0.76
- Dividend yield
- 0.62%
- Last payment
- $0.21
- Ex-dividend date
- Oct 1, 2026
Encompass Health peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| DVADaVita Inc. | 176.78 | -2.01% | $11.28B | vs EHC |
| FMSFresenius Medical Care AG ADR | 20.69 | -7.72% | $11.01B | vs EHC |
| UHSUniversal Health Services Inc. | 174.62 | -1.39% | $10.29B | vs EHC |
| ENSGThe Ensign Group Inc. | 169.22 | -1.65% | $9.86B | vs EHC |
| PACSPACS Group Inc. | 43.19 | +0.89% | $6.84B | vs EHC |
| CHEChemed Corp | 501.45 | -1.65% | $6.55B | vs EHC |
| OPCHOption Care Health Inc. | 31.01 | +0.03% | $4.65B | vs EHC |
| CONConcentra Group Holdings Parent Inc. | 36.40 | 0.00% | $4.64B | vs EHC |
Indexes, lists and sector
Encompass Health stock FAQ
What is Encompass Health's stock price today?
EHC last traded at $122.48 as of Oct 7, 4:00 PM EDT, down 1.77% on the day. Prices are delayed at least 15 minutes.
Does Encompass Health pay a dividend?
Yes. Encompass Health pays $0.76 per share annually, a 0.62% yield. The most recent dividend of $0.21 had an ex-dividend date of Oct 1, 2026.
When is Encompass Health's next earnings date?
Encompass Health is expected to report earnings on Wednesday, October 28, 2026. Analysts expect EPS of $1.37.
What is EHC's P/E ratio?
EHC trades at a trailing P/E ratio of 20.48 and a forward P/E of 18.34, compared with a median of 23.5 for its closest peers.
Who is Encompass Health's CEO?
Mr. Mark J. Tarr is the chief executive officer of Encompass Health Corporation, which has about 29,699 employees.
Has EHC ever split its stock?
Yes. The most recent EHC stock split was a 1257-for-1000 split on Jul 1, 2022, one of 5 splits on record.
What is the EHC 52-week high?
The 52-week high for EHC is $127.99 and the 52-week low is $92.77. The stock is currently 4.3% below its high.